<html>
<head>PUBMED IDs for NY-SAR-35</head>
<body bgcolor='#C5F0F2'><h1>NY-SAR-35</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12601173/'>Immunomic analysis of human sarcoma.</a> February 26  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/21318630/'>Expression of the human cancer/testis antigen NY-SAR-35 is activated by CpG island hypomethylation.</a> August 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/26648093/'>Cancer/testis antigen NY-SAR-35 enhances cell proliferation, migration, and invasion.</a> September 28  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/28126340/'>A cancer/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells.</a> January 28  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28356959/'>Effect of cancer/testis antigen NY-SAR-35 on the proliferation, migration and invasion of cancer cells.</a> March 31  2017<br></body></html>
